Development of a Novel Drug Delivery System, Time-Controlled Explosion System (TES). IV.<i>In Vivo</i>Drug Release Behavior
Satoshi Ueda(Mochida Pharmaceutical (Japan)), Takehisa Hata, Saburo Murata(Mochida Pharmaceutical (Japan)), Sumihisa Kimura(Mochida Pharmaceutical (Japan)), Toshiya Takahashi(Tohoku University), Akio Kawamura(Mochida Pharmaceutical (Japan)), Rinta Ibuki(Fujisawa City Hospital)
Cited by 30
Related Papers
Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double‐Blind, Randomized, Parallel‐Group Trial
|Arthritis & Rheumatology|2016|119
Psoriasis and Antimicrobial Peptides
|International Journal of Molecular Sciences|2020|114
An In Vitro Test to Screen Skin Sensitizers Using a Stable THP-1–Derived IL-8 Reporter Cell Line, THP-G8
|Toxicological Sciences|2011|93
Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors
|Scientific Reports|2018|84